艾昆纬-为东南亚制药行业带来变革性影响（英）-2023-12页_407kb

Southeast Asia Pharmaceutical Industry Transformation Summary

Context

• Southeast Asia's pharmaceutical industry faces VUCA conditions (Volatility, Uncertainty, Complexity, Ambiguity) marked by fluctuating demand, supply chain unpredictability, evolving technologies, and health system disruptions like COVID-19.
• The region offers strong growth due to rising personal income, an expanding middle-class, increased private insurance, and higher incidences of chronic diseases such as diabetes and cardiovascular disorders.

Imperative for Transformation

• Companies must adopt transformative actions beyond competitiveness to capture leading positions in the market.
• Key transformative themes include: digitalization, scaling novel innovations (e.g., mRNA, cell & gene therapies), leveraging partnerships, embracing agile remote work, and rethinking talent strategies.

Transformation Tenets

1. Shoot for the Moon

• Set highly ambitious, top-down goals significantly exceeding traditional revenue targets, supported by senior leadership alignment.
• Think like a "Day 1" startup, focusing aggressively on growth from multiple fronts.

2. Sing the Same Song

• Craft an integrated narrative detailing growth objectives, transformation pillars, operational changes, and motivations for transition.
• Employ continuous, adapted communication tailored to different audiences via roadshows, town halls, memos, etc., while busting associated myths.

3. Start with Low Hanging Fruit

• Identify quick win initiatives early to build initial momentum, executing them within 3-4 months while planning long-term levers.
• Foster action bias with "just enough" planning; initiate pilots swiftly when proof points are sufficient.

4. Build as You Fly

• Implement initiatives simultaneously across diverse business segments (products, channels, regions) to hedge uncertainties and achieve a robust aggregate return.
• Establish an enabling framework (PMO/TMO) for tracking, de-bottlenecking, and leadership access.

5. Put Your Eggs in Multiple Baskets

• Design transformation as a conveyor belt of success for contributors, linking it to career progression opportunities and targeted performance measurement.

6. Leverage Transformation as an Accelerator/Enabler

• Strategically position transformation as a resource accelerator for ideas, providing budget and senior attention for de-bottlenecking.

7. Provide "Skin in the Game"

• Integrate financial and non-financial incentives (bonuses, recognition, growth support) to motivate participation and align rewards with transformation outcomes, addressing concerns about undue scrutiny.

8. Assess and Build Required Capabilities

• Surface and address capability gaps through competency frameworks, 360 feedback, performance reviews, role placement, and comprehensive upskilling.

Conclusion

Successful transformation in Southeast Asia's pharmaceutical industry depends on strategic aims, unified messaging, prioritized execution, adaptability, enabling infrastructure, incentivized participation, and proactive capability building to capture market leadership in a dynamic environment.